Tsveta Milanova is CCO at AGIOS PHARMACEUTICALS, INC. (AGIO). They have made 1 open-market trade across 1 company since 2023, most recently 2026-04-02.
CIK 0001957180
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| AGIO | 46,829 | $1.5M |
Shares reported on the most recent Form 4, priced at the 2026-04-06 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AGIO | SELL · 10b5-1 | 2026-04-02 | 2026-04-06 | $34.71 | $113K | +0.3% | -22.5% | +7.5% |
| AGIO | SELL · 10b5-1 | 2026-03-02 | 2026-03-03 | $28.96 | $83K | -2.9% | +22.8% | -2.3% |
| AGIO | SELL · 10b5-1 | 2026-01-05 | 2026-01-07 | $27.02 | $78K | -5.5% | -6.1% | +24.3% |
| AGIO | SELL · 10b5-1 | 2025-12-30 | 2026-01-02 | $27.09 | $79K | +5.7% | +3.6% | +29.6% |
| AGIO | SELL · 10b5-1 | 2025-06-24 | 2025-06-26 | $33.54 | $186K | +16.1% | +10.5% | +10.9% |
| AGIO | SELL · 10b5-1 | 2025-03-03 | 2025-03-04 | $35.54 | $119K | -7.8% | -17.4% | -2.7% |
| AGIO | SELL · 10b5-1 | 2025-01-06 | 2025-01-07 | $32.18 | $180K | -5.4% | -2.0% | -26.3% |
| AGIO | SELL · 10b5-1 | 2024-01-24 | 2024-01-24 | $21.64 | $35K | +9.0% | +51.5% | +46.1% |
| AGIO | SELL · 10b5-1 | 2024-01-05 | 2024-01-05 | $22.32 | $130K | -7.5% | +3.0% | +21.2% |
| AGIO | SELL | 2023-06-30 | 2023-06-30 | $28.36 | $46K | -0.6% | -5.7% | -11.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.